Trump Drops an F-Bomb on Maduro
Trump’s Brilliant Iran Play
A Hamas Fighter Helped Slaughter Israelis – Then Moved to This State
Karoline Leavitt Fires Back at Hakeem Jeffries and She Brings the Receipts
Abigail Spanberger Finds It 'Horrifying' That President Trump Is Enforcing Immigration Law...
Sen. Ted Cruz Warns Soros Network Is Bankrolling ‘No Kings’ Protests, Promotes Stop...
Fairfax County Schools Double Down After Whistleblower Exposes Secret Student Abortions
Fed Up Parents Make Maine School Board Squirm Over Trans Locker Room Policies
A Warning Against the Unmooring of the American Right
Snopes Plays Cover for What Could Become a National Gun Registry
Arc De Trump
Transgenderism and LGBTQ Ideology Is in Decline on American College Campuses
This Top Democrat Just Hit Karoline Leavitt With Vicious Personal Attacks
Kristie Noem's Airport Video Triggers Michigan Lawmaker
Feds: Woman Screamed Death Threats During Immigration Arrest
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement